Lv4
470 积分 2024-10-09 加入
Unlocking the potential of agonist antibodies for treating cancer using antibody engineering
4天前
已完结
The present and future of bispecific antibodies for cancer therapy
4天前
已完结
Targeting the TNF and TNFR superfamilies in autoimmune disease and cancer
4天前
已完结
Bispecific and multispecific antibodies in oncology: opportunities and challenges
4天前
已完结
Opportunities and challenges of targeting cGAS–STING in cancer
4天前
已完结
Radiation as an immune modulator: mechanisms and implications for combination with immunotherapy
10天前
已完结
Macrophage-targeted immunocytokine leverages myeloid, T, and NK cell synergy for cancer immunotherapy
15天前
已完结
Combination strategies with STING agonists: Current advances and future directions
16天前
已完结
Macrophages: Targets for next-generation cancer immunotherapy
24天前
已完结
Resistance to PD1/PDL1 checkpoint inhibition
1个月前
已完结
皖公网安备34019202002308
